Approval · Notice of Compliance 4295 · 1996
SYN-CAPTOPRIL: Notice of Compliance 4295
Issued April 25, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4295
- Date
- April 25, 1996
- Company
- Syncare Pharmaceutical Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product monograph revisions
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYN-CAPTOPRIL | 02218356 | — |
| SYN-CAPTOPRIL | 02218364 | — |
| SYN-CAPTOPRIL | 02218372 | — |
| SYN-CAPTOPRIL | 02218380 | — |